Common Contracts
27 similar Employment Agreement contracts by PTC Therapeutics, Inc., Ocular Therapeutix, Inc
EMPLOYMENT AGREEMENTEmployment Agreement • April 25th, 2024 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of May 4, 2020 (the “Effective Date”), by and between PTC Therapeutics, Inc., a Delaware corporation (the “Company”) and Lee Golden (“Executive”). In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • February 22nd, 2022 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of October 28, 2019 (the “Effective Date”), by and between PTC Therapeutics, Inc., a Delaware corporation (the “Company”) and Matthew Klein (“Executive”). In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • March 11th, 2021 • Ocular Therapeutix, Inc • Pharmaceutical preparations • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is made on August 28, 2020, by and between Ocular Therapeutix, Inc., a Delaware corporation (the “Company”), and Philip C. Strassburger (“Executive”) and the employment relationship between the Company and the Executive shall be governed by this Agreement commencing as of the Effective Date (as defined below) and continuing in effect until terminated by either party in accordance with this Agreement. In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • August 5th, 2020 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of October 28, 2019 (the “Effective Date”), by and between PTC Therapeutics, Inc., a Delaware corporation (the “Company”) and Matthew Klein (“Executive”). In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • August 5th, 2020 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of March 9, 2015 (the “Effective Date”), by and between PTC Therapeutics, Inc., a Delaware corporation (the “Company”) and Eric Pauwels (“Executive”). In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • May 8th, 2020 • Ocular Therapeutix, Inc • Pharmaceutical preparations • Massachusetts
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of April 21, 2019 (the “Effective Date”), by and between Ocular Therapeutix, Inc., a Delaware corporation (the “Company”), and Patricia Kitchen (“Executive”). In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EX-10.15 15 d679502dex1015.htm EX-10.15 EMPLOYMENT AGREEMENTEmployment Agreement • May 5th, 2020 • Massachusetts
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of June 19, 2014, by and between Ocular Therapeutix, Inc., a Delaware corporation (the “Company”), and James Fortune (“Executive”). This Agreement amends and restates in its entirety the Employment Offer Letter between the Company and Executive dated August 24, 2009 (the “Offer Letter”). This Agreement shall be effective only upon the closing of an IPO (as defined below) (the “Effective Date”). If no IPO occurs, the Offer Letter shall remain in full force and effect. In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • August 6th, 2019 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of August 16, 2014 (the “Effective Date”), by and between PTC Therapeutics, Inc., a Delaware corporation (the “Company”) and Christine Utter (“Executive”). In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • August 6th, 2019 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of December 11, 2017 (the “Effective Date”), by and between PTC Therapeutics, Inc., a Delaware corporation (the “Company”) and Emily Hill (“Executive”). In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • September 25th, 2017 • Ocular Therapeutix, Inc • Pharmaceutical preparations • Massachusetts
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of September 25, 2017 (the “Effective Date”), by and between Ocular Therapeutix, Inc., a Delaware corporation (the “Company”), and Donald Notman (“Executive”). In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • August 9th, 2017 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of August 16, 2014 (the “Effective Date”), by and between PTC Therapeutics, Inc., a Delaware corporation (the “Company”) and Christine Utter (“Executive”). In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • August 9th, 2017 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of July 8, 2014 (the “Effective Date”), by and between PTC Therapeutics, Inc., a Delaware corporation (the “Company”) and Marcio Silva de Souza (“Executive”). In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • June 22nd, 2017 • Ocular Therapeutix, Inc • Pharmaceutical preparations • Massachusetts
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of June 20, 2017, by and between Ocular Therapeutix, Inc., a Delaware corporation (the “Company”), and Antony C. Mattessich (“Executive”). In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • November 9th, 2016 • Ocular Therapeutix, Inc • Pharmaceutical preparations • Massachusetts
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of January 5, 2016 by and between Ocular Therapeutix, Inc., a Delaware corporation (the “Company”), and Jon Talamo, M.D. (“Executive”). In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • November 9th, 2016 • Ocular Therapeutix, Inc • Pharmaceutical preparations • Massachusetts
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of October 10, 2016 (the “Effective Date”), by and between Ocular Therapeutix, Inc., a Delaware corporation (the “Company”), and Andy Hurley (“Executive”). In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 11th, 2014 • Ocular Therapeutix, Inc • Pharmaceutical preparations • Massachusetts
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is made as of June 24, 2014, by and between Ocular Therapeutix, Inc., a Delaware corporation (the “Company”), and Dr. Amarpreet S. Sawhney (“Executive”). This Agreement amends and restates in its entirety the Employment Agreement between the Company and Executive dated December 31, 2007 (the “Existing Employment Agreement”). This Agreement shall be effective only upon the closing of an IPO (as defined below) (the “Effective Date”). If no IPO occurs, the Existing Employment Agreement shall remain in full force and effect. In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • July 11th, 2014 • Ocular Therapeutix, Inc • Pharmaceutical preparations • Massachusetts
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of July 3, 2014, by and between Ocular Therapeutix, Inc., a Delaware corporation (the “Company”), and Eric Ankerud (“Executive”). This Agreement amends and restates in its entirety the Employment Offer Letter between the Company and Executive dated April 1, 2009 (the “Offer Letter”). This Agreement shall be effective only upon the closing of an IPO (as defined below) (the “Effective Date”). If no IPO occurs, the Offer Letter shall remain in full force and effect. In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • July 11th, 2014 • Ocular Therapeutix, Inc • Pharmaceutical preparations • Massachusetts
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of June 19, 2014, by and between Ocular Therapeutix, Inc., a Delaware corporation (the “Company”), and James Fortune (“Executive”). This Agreement amends and restates in its entirety the Employment Offer Letter between the Company and Executive dated August 24, 2009 (the “Offer Letter”). This Agreement shall be effective only upon the closing of an IPO (as defined below) (the “Effective Date”). If no IPO occurs, the Offer Letter shall remain in full force and effect. In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • July 11th, 2014 • Ocular Therapeutix, Inc • Pharmaceutical preparations • Massachusetts
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of June 24, 2014, by and between Ocular Therapeutix, Inc., a Delaware corporation (the “Company”), and Brad Smith (“Executive”). This Agreement amends and restates in its entirety the Employment Offer Letter between the Company and Executive dated March 11, 2014 (the “Offer Letter”). This Agreement shall be effective only upon the closing of an IPO (as defined below) (the “Effective Date”). If no IPO occurs, the Offer Letter shall remain in full force and effect. In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • May 6th, 2014 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of January 23, 2014 (the “Effective Date”), by and between PTC Therapeutics, Inc., a Delaware corporation (the “Company”) and Robert Spiegel, MD (“Executive”). In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • June 5th, 2013 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of June 3, 2013 (the “Effective Date”), by and between PTC Therapeutics, Inc., a Delaware corporation (the “Company”) and Shane Kovacs (“Executive”). In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • May 28th, 2013 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of May 24, 2013 (the “Effective Date”), by and between PTC Therapeutics, Inc., a Delaware corporation (the “Company”) and Mark Rothera (“Executive”). In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • May 28th, 2013 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of May 22, 2013 (the “Effective Date”), by and between PTC Therapeutics, Inc., a Delaware corporation (the “Company”) and Jay Barth, M.D. (“Executive”). In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 28th, 2013 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is made as of May 22, 2013 (the “Effective Date”), by and between PTC Therapeutics, Inc., a Delaware corporation (the “Company”) and Mark Boulding (“Executive”). This Agreement amends and restates in its entirety the Employment Agreement between the Company and Executive dated December 14, 2004, as amended by letter agreement dated December 18, 2008. In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 28th, 2013 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is made as of May 22, 2013 (the “Effective Date”), by and between PTC Therapeutics, Inc., a Delaware corporation (the “Company”) and Neil Almstead, Ph.D. (“Executive”). This Agreement amends and restates in its entirety the Employment Agreement between the Company and Executive dated December 14, 2004, as amended by letter agreement dated December 18, 2008. In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 28th, 2013 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is made as of May 24, 2013 (the “Effective Date”), by and between PTC Therapeutics, Inc., a Delaware corporation (the “Company”) and Cláudia Hirawat (“Executive”). This Agreement amends and restates in its entirety the Employment Agreement between the Company and Executive dated December 14, 2004, as amended by letter agreement dated December 18, 2008. In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 28th, 2013 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is made as of May 22, 2013 (the “Effective Date”), by and between PTC Therapeutics, Inc., a Delaware corporation (the “Company”) and Stuart W. Peltz (“Executive”). This Agreement amends and restates in its entirety the Employment Agreement between the Company and Executive dated October 29, 2009. In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
